Related Experiment Videos
Electron transport chain defects in heart failure.
1Muscle Research Unit, Department of Internal Medicine, Hospital Clínic, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona, Catalonia, Spain. jordi@medicina.ub.es
Heart Failure Reviews
|May 4, 2002
Summary
Mitochondrial dysfunction in the heart
Area of Science:
- Cardiology
- Mitochondrial Biology
- Metabolic Disorders
Background:
- Cardiac metabolism disorders are increasingly implicated in heart failure pathogenesis.
- Mitochondrial electron transport chain (ETC) dysfunction is observed in dilated cardiomyopathies.
- The role of mitochondrial dysfunction in idiopathic dilated cardiomyopathy (IDC) is debated, possibly secondary to oxidative stress.
Purpose of the Study:
- To review current knowledge on mitochondrial function in failing myocardium.
- To discuss the role of mitochondrial dysfunction in systolic heart failure, particularly IDC.
- To explore the potential link between oxidative damage and ETC dysfunction in heart failure.
Main Methods:
- Review of existing literature on mitochondrial function in heart failure.
- Focus on systolic heart failure and idiopathic dilated cardiomyopathy.
- Discussion of histological, biochemical, and molecular studies of mitochondrial abnormalities.
Main Results:
- Abnormalities in mitochondrial DNA genes encoding ETC components are reported in dilated cardiomyopathies.
- Mitochondrial dysfunction may be a secondary phenomenon in IDC, potentially due to increased oxidative damage.
- ETC dysfunction can contribute to the progression of heart failure, regardless of its origin.
Conclusions:
- Modulating cardiac metabolism could be a potential therapeutic strategy for IDC.
- Further research is needed to confirm the role of mitochondrial dysfunction and oxidative stress in heart failure.
- Understanding the precise mechanisms of heart failure requires considering energy metabolism alongside other factors.